Milad Shirvaliloo | Genetics and Genomics | Best Researcher Award

Published on by Popular Engineer

Dr. Milad Shirvaliloo | Genetics and Genomics | Best Researcher Award

Iran University of Medical Sciences | Iran

Milad Shirvaliloo holds an MD and an MBA in Health Sciences and is an aspiring physician-researcher with over six years of investigative experience in epigenetics, cancer biology and pulmonary medicine. He has published more than 40 peer-reviewed articles and a book chapter, and serves on the Editorial Board of Epigenomics and as reviewer for 60+ Web of Science-indexed journals. His academic journey includes medical education at Tabriz University of Medical Sciences and postgraduate research at Iran University of Medical Sciences  focusing on nanoparticle-based therapeutic interventions and histone acetylation in cancer. His work spans diagnostics (e.g., nano-biosensor assays for SARS-CoV-2), lung epithelium development (epigenetic cues in human lung organoids) and cancer nano-theranostics (targeted magnetochemotherapy and histone modification mapping). According to h-index is 16 and he has amassed over 819 citations to date. His main research interests include histone modifications, chromatin accessibility, nanoparticle-mediated drug delivery and epigenetic biomarkers in respiratory and oncologic diseases. He brings strong skills in scientific communication, evidence synthesis, statistical & bioinformatics analysis and R programming. In conclusion, Milad’s interdisciplinary expertise positions him at the interface of molecular epigenetics and translational nanomedicine with the aim to advance precision diagnostics and therapies.

Profiles : Scopus | Google Scholar 

Featured Publications

Heris, R. M., Shirvaliloo, M., Abbaspour-Aghdam, S., Hazrati, A., Shariati, A., & Youshanlouei, H. R., et al. (2022). The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment. Stem Cell Research & Therapy, 13(1), 371.

Sheervalilou, R., Shirvaliloo, M., Dadashzadeh, N., Shirvalilou, S., Shahraki, O., & Pilehvar-Soltanahmadi, Y., et al. (2020). COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease. Journal of Cellular Physiology, 235(12), 8873–8924.

Aghbash, P. S., Eslami, N., Shirvaliloo, M., & Baghi, H. B. (2021). Viral coinfections in COVID‐19. Journal of Medical Virology, 93(9), 5310–5322.

Shirvalilou, S., Khoei, S., Esfahani, A. J., Kamali, M., Shirvaliloo, M., & Sheervalilou, R., et al. (2021). Magnetic hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A systematic review. Journal of Neuro-Oncology, 152(3), 419–428.

Razlansari, M., Jafarinejad, S., Rahdar, A., Shirvaliloo, M., Arshad, R., & Fathi-Karkan, S., et al. (2023). Development and classification of RNA aptamers for therapeutic purposes: An updated review with emphasis on cancer. Molecular and Cellular Biochemistry, 478(7), 1573–1598.

Marwa Hassan | Molecular Biology | Best Researcher Award

Published on by Popular Engineer

Assist. Prof. Dr. Marwa Hassan | Molecular Biology | Best Researcher Award

Theodor Bilharz Research Institute | Egypt

Marwa Hassan is an immunologist with substantive contributions in stem cell biology, molecular immunology, and translational research. She also holds a Postgraduate Diploma in Healthcare & Hospital Management (American University in Cairo, 2020). Over her career she has held roles from resident researcher to acting head of department at the Immunology Division of TBRI, and has organized and led numerous specialized training courses (e.g. stem cell culture, molecular immunology, ELISA). Her research interests include non-coding RNAs, stem cell differentiation, immune regulation in liver disease, and biomarker development. She has published in peer-reviewed journals (e.g. on circulating liver cancer stem cells) and contributed to capacity building via workshops and academic leadership. Her awards and recognitions reflect her dual strengths in research and academic service. In sum, Dr. Hassan combines rigorous scientific inquiry with institutional leadership, advancing immunology and regenerative medicine in Egypt and beyond.

Profile : Orcid

Featured Publications

Ahmed, M. H. M., & Abdel Hamid, H. M. (2022). Circulating liver cancer stem cells: Clinical implications and future perspectives. World Journal of Gastroenterology, 28(1), 39–52

Ahmed, M. H. M., El Refai, S., & El-Shenawy, R. (2021). MicroRNA-based biomarkers in hepatitis C virus-induced hepatocellular carcinoma. Egyptian Journal of Immunology, 28(2), 75–90.

Ahmed, M. H. M., Hussein, M., & El Sayed, A. (2020). Impact of mesenchymal stem cell passaging on proliferation and differentiation potential. Theodor Bilharz Medical Journal, 18(4), 201–210.

Ahmed, M. H. M., Ibrahim, N., & Khalifa, M. (2019). Role of regulatory T-cells in autoimmune liver diseases: An immunopathological study. Journal of Clinical and Experimental Hepatology, 9(3), 355–362.

Ahmed, M. H. M., & El Demerdash, R. (2017). Gene expression profiling of umbilical cord blood-derived mesenchymal stem cells under oxidative stress. Stem Cell Research & Therapy, 8(1), 112.

Ehsan Khedre | Biology and Life Sciences | Best Researcher Award

Published on by Popular Engineer

Dr. Ehsan Khedre | Biology and Life Sciences | Best Researcher Award

Egyptian Drug Authority Pyramids Branch | Egypt

Dr. Ehsan Khedre is a pharmaceutical biochemistry researcher whose work spans natural product pharmacology, nanotechnology, oxidative stress, and metabolic disease. After earning her B.Pharm (Ain-Shams University, Egypt, 2004), she completed an M.Sc. in Biochemistry (Zagazig University, 2011) and a Ph.D. (Al-Azhar University, 2018) on estrogenic effects of quercetin and its nanoparticles. She has held roles at Egypt’s National Organization for Drug Control & Research (NODCAR / EDA), advancing from drug control specialist to quality manager and researcher in biochemical laboratories. Her publication record (to date > 9 peer-reviewed articles) includes studies on hepatic fibrosis, nanocarrier enhancement of phytochemicals, metabolic syndrome models, and nanoparticle biodistribution. Her citation metrics h-index of 5, total documents 7, total citations 170 reflect her growing impact in pharmacology and toxicology. Her research interests include antioxidant and anti-inflammatory natural compounds, nanoparticle delivery systems, biochemical mechanisms of organ injury, and translational approaches to metabolic and hepatic diseases. She has also contributed by serving as reviewer for journals, receiving training in quality systems (ISO 9001 / ISO 17025), scientific writing, bioinformatics, and innovation, and participating in workshops on research skills. In sum, Dr. Khedre combines deep domain expertise, laboratory leadership, and interdisciplinary scholarship to advance discovery and application of therapeutics.

Profiles : Orcid | Scopus

Featured Publications

Fayed, E. A., El-Sebaey, S. A., Ebrahim, M. A., Abu-Elfotuh, K., El-Sayed Mansour, R., Mohamed, E. K., Hamdan, A. M. E., Al-subaie, F. T., Albalawi, G. S., Albalawi, T. M., et al. (2025). Discovery of novel bicyclic and tricyclic cyclohepta[b]thiophene derivatives as multipotent AChE and BChE inhibitors, in-vivo and in-vitro assays, ADMET and molecular docking simulation. European Journal of Medicinal Chemistry, 117201.

Abu-Elfotuh, K., Kamel, G. A. M., Najm, M. A. A., Hamdan, A. M. E., Koullah, M. T., Fahmy, R. K. E., Aboelsoud, H. A., Alghusn, M. A., Albalawi, B. R., Atwa, A. M., et al. (2025). Modulating multiple molecular trajectories by nutraceuticals and/or physical activity in attention-deficit/hyperactivity disorder (ADHD)-like behaviors in rat pups. Journal of NeuroImmune Pharmacology.

Oudah, K. H., Najm, M. A. A., Ramsis, T. M., Ebrahim, M. A., Gohar, N. A., Abu-Elfotuh, K., Mohamed, E. K., Hamdan, A. M. E., Hamdan, A. M., Almotairi, R., et al. (2025). Unlocking therapeutic potential of novel thieno-oxazepine hybrids as multi-target inhibitors of AChE/BChE and evaluation against Alzheimer’s disease: In vivo, in vitro, histopathological, and docking studies. Pharmaceuticals, 18(8), 1214.

Nazeam, J. A., Black, I., Mulamoottil, V. A., Selim, N. M., El Shiekh, R. A., Abu-Elfotuh, K., Hamdan, A. M. E., Gowifel, A. M. H., Hafez, S. M., Mohamed, E. K., et al. (2025). Okra seed polysaccharides mitigate neuroinflammation and cognitive impairment via modulation of Nrf2/HO-1, HMGB1/RAGE/TLR4/NF-κB, NLRP3/Caspase-1, JAK-2/STAT-3, AMPK/SIRT1/m-TOR, PI3K/AKT/CREB/BDNF/TrkB and PERK/CHOP/Bcl-2 axes. International Immunopharmacology, 114110.

Mohamed, E. K., Fathy, M. M., Sadek, N. A., & Eldosoki, D. E. (2024). The effects of rutin coat on the biodistribution and toxicities of iron oxide nanoparticles in rats. Journal of Nanoparticle Research, 26(3), 49.